Budapest, Hungary

András Ferenc Wacha

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Egis Gyogyszergyar Zrt.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: András Ferenc Wacha. Retrieved from https://idiyas.com/inventor/andrás-ferenc-wacha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: András Ferenc Wacha: Innovator in Topical Pharmaceutical Compositions

Introduction

András Ferenc Wacha is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions that enhance therapeutic effects.

Latest Patents

Wacha holds a patent for a topical pharmaceutical composition containing phospholipids. This innovative formulation includes pregabalin and a reduced micellar phospholipid as an active ingredient. The invention is designed to provide a prolonged analgesic effect of pregabalin, effectively reducing neuropathic pain for at least five hours.

Career Highlights

Wacha is associated with Egis Gyógyszergyár Zrt., a prominent pharmaceutical company in Hungary. His work focuses on advancing pharmaceutical formulations that improve patient outcomes and enhance the efficacy of existing medications.

Collaborations

Wacha collaborates with talented professionals in his field, including Anita Gulyás and Krisztina Móricz. Their combined expertise contributes to the innovative projects at Egis Gyógyszergyár Zrt.

Conclusion

András Ferenc Wacha is a distinguished inventor whose work in topical pharmaceutical compositions demonstrates his commitment to improving healthcare solutions. His contributions are paving the way for more effective treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…